High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases - Wikidata - wikimedia - TriplyDB

High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases

High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases

http://www.wikidata.org/entity/Q34986999

about

Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.Haematopoietic stem cell transplantation for autoimmune diseases.Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies.Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.

P2860

Q34522797-5B539025-B1DE-406D-BDDC-1F226B80A5BD Q34551863-B2F54028-2694-46CF-85F6-BD735F38F766 Q36562866-8F6A9237-5C73-4E52-9651-295A89225B1D Q36730633-7753E90D-CD08-4552-BB1D-B1BDC7EE513E Q37250343-DB6D48C9-4718-4032-8B7C-557F65B58C11 Q41814408-226A5800-05BB-4E9D-9799-DDEB55D8380A Q47962680-F0F39B7D-439C-4082-B0CA-E8CFC3FEC131

P2860

High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases

http://www.wikidata.org/entity/Q34986999

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@ast

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@en

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@nl

type

label

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@ast

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@en

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@nl

prefLabel

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@ast

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@en

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@nl

P1433

Q34986999-9DA4A014-BD7C-486D-BEE2-55CF94A02239

P1476

Q34986999-E7E4ABAA-7581-451B-A3F5-4D7340844FD3

P2093

Q34986999-0DAA98C6-84F4-4268-A1D8-10AE5F73FD54

Q34986999-1022F265-1991-42B9-A8B8-9C58FD7CB8FF

Q34986999-10F87E3D-5083-476C-ACAA-04FE7AC596C9

Q34986999-304AFC19-337F-419E-950B-C191CD65782D

Q34986999-33A73EE6-9CB1-4B21-9713-DB8F2E76ED16

Q34986999-4AA73FAC-CB6B-4739-89F0-D1C75713728C

Q34986999-BCEA5661-C2D1-451E-B714-51EEBE36329C

Q34986999-C738FF43-15D2-4A51-9F8D-985F20881F75

Q34986999-CAC87B42-C5A5-4D09-B9A8-638D7F7FC1FB

Q34986999-CB25D08F-7F81-4E84-B4C1-4EE8BEC050E0

P2860

Q34986999-09ECF35F-3D3B-49BD-B0CE-98DCCE2D16B5

Q34986999-0C5592F1-E0D2-439B-B88B-3855E79F73ED

Q34986999-0FE687B0-DE44-47EB-90EE-8C355F46AEB5

Q34986999-1A923BBA-B5A6-4DBE-8E18-048A06E3F08C

Q34986999-2D834480-464D-48C2-851A-32ACF3FA3F4B

Q34986999-36EBB622-7A01-4BAC-B16B-E69B86ED6617

Q34986999-37F755B8-4686-4D28-88AF-C092A646BC28

Q34986999-59BF34D3-AF2A-4C45-8954-32C7C63267C8

Q34986999-5B3BC878-6B12-4B6C-A0D1-BB48A93856AA

Q34986999-600872B9-8886-4488-BD8C-5C379EE0D160

P304

Q34986999-18A5FA0C-2548-4C64-8650-21D45DAEF3A4

P31

Q34986999-A49E66D3-008A-4736-801A-DF4A78F32135

P356

Q34986999-2A2BCECF-64DA-48D1-B6EB-32FBE9C39A97

P407

Q34986999-99181462-C38D-4803-9236-563BD89832D1

P433

Q34986999-05A54A25-8DAD-465B-8664-0A35791BB089

P478

Q34986999-2AB7D726-1FA7-4A34-98E8-99420ACCB5DB

P50

Q34986999-F1146D66-2081-4D59-81FE-578D93CF12BD

P577

Q34986999-6B5860A6-5549-44EA-8FA1-35E1B6035620

P698

Q34986999-CFA57ED4-E780-4823-BBE0-2F1B411016AB

P932

Q34986999-0C3899F2-279A-4879-87FA-5274270C9167

P356

MD.0B013E318210E685

P1433

P1476

High-dose cyclophosphamide wit ...... and other autoimmune diseases

@en

P2093

Amy E DeZern

http://www.w3.org/2001/XMLSchema#string

Daniel B Drachman

http://www.w3.org/2001/XMLSchema#string

David M Loeb

http://www.w3.org/2001/XMLSchema#string

Doug Kerr

http://www.w3.org/2001/XMLSchema#string

Edward R Hammond

http://www.w3.org/2001/XMLSchema#string

Fredrick Wigley

http://www.w3.org/2001/XMLSchema#string

Grant Anhalt

http://www.w3.org/2001/XMLSchema#string

Hua-Ling Tsai

http://www.w3.org/2001/XMLSchema#string

Jeanne Kowalski

http://www.w3.org/2001/XMLSchema#string

Richard J Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis

Current concepts in the pathophysiology and treatment of aplastic anemia

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.

Bone marrow transplantation for autoimmune diseases.

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial

High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes

Cyclophosphamide and cancer: golden anniversary.

P304

89-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0B013E318210E685

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A. Petri

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21358440

http://www.w3.org/2001/XMLSchema#string

P932

3096466

http://www.w3.org/2001/XMLSchema#string